Navigation Links
Discovery of controlled swarm in bacteria
Date:6/22/2010

A study led by researchers from Universitat Autnoma de Barcelona (UAB) describes one of the mechanisms in which pathogenic bacteria populations control the way they spread over the surface of the organs they infect and stop when they detect the presence of an antibiotic, only to resume again when the effect wears off. The star of this process is the RecA protein, which significantly increases its concentration at the start of the bacteria DNA repair mechanism induced by antibiotics. The research was published in Infection and Immunity.

In order to develop the infectious process, many pathogenic bacteria move collectively along the surface of the organ they infect until growing into a massive colony, and consequently produce toxins and substances that harm host tissues. This movement is known as swarming, similar to the movement of bee colonies and other animals. Parts of the molecular process taking place during this movement already have been described, but the mechanism controlling activation or inhibition was not yet known.

The research reveals for the first time the relation between the bacteria DNA repair system, known as SOS response, and swarming. Researchers demonstrated that the presence of antibiotics activates SOS response and thus increases concentration of RecA protein. This interferes with the action of the CheW protein, essential for swarming, and thus causes the bacterial colony to stop moving. When the concentration of this antibiotic decreases, the amount of RecA protein reduces and CheW once again can continue its task of spreading the bacteria.

The results obtained indicate that given the special characteristics of this type of collective movement, antibiotics only affect outer cells of the swarm, which in turn act as sensors and activate the aforementioned molecular repair system. This action thus cancels out the effect of the drug on the rest of the bacteria population.

Jordi Barb, Laura Medina Ruiz and Susana Campoy, researchers at UAB's Department of Genetics and Microbiology and directors of the study, highlight the importance of this basic discovery since it will allow for the design of targets blocking RecA action and thus increase antibiotic sensitivity of bacteria.

The research was carried out with Salmonella enterica, member of a bacteria group found in several pathogenic species responsible for diseases in the digestive and respiratory system, such as septicaemia and systemic infections.

Working alongside UAB researchers were Cristina Latasa of the Institute for Agrobiotechnology-Public University of Navarre-CSIC-Government of Navarre, and Paula Crdenas and Juan Carlos Alonso of the National Biotechnology Centre belonging to the Spanish Higher Council for Scientific Research (CSIC).


'/>"/>

Contact: Maria Jesus Delgado
MariaJesus.Delgado@uab.cat
34-935-814-049
Universitat Autonoma de Barcelona
Source:Eurekalert  

Related biology news :

1. Molecular discovery suggests new strategy to fight cancer drug resistance
2. New discovery could aid development of elusive bovine mastitis vaccine
3. Medical researchers discovery may explain how certain cancers develop
4. Discovery may lead to safer drinking water, cheaper medicine: Queens University researchers
5. Discovery: Yeast make plant hormone that speeds infection
6. Discovery of stem cell illuminates human brain evolution, points to therapies
7. Covance Establishes New Discovery & Translational Services Group
8. Parallel brainstem circuit discovery suggests new path in Parkinsons research
9. Covance Establishes New Discovery & Translational Services Group
10. Gene discovery may lead to new varieties of soybean plants
11. Discovery of a primate more than 11 million years old
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Discovery of controlled swarm in bacteria
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: